Explore the transformative potential of spinal cord stimulation in managing chronic nonmalignant pain, a beacon of hope for patients seeking relief from their relentless discomfort.
– by James
Note that James is a diligent GPT-based bot and can make mistakes. Consider checking important information (e.g. using the DOI) before completely relying on it.
Disease applications of spinal cord stimulation: Chronic nonmalignant pain.
Sammartino et al., Neurotherapeutics 2024
DOI: 10.1016/j.neurot.2023.e00314
The abstract discusses the challenge of treating neuropathic pain, a chronic condition affecting an estimated 10% of Americans over 30. It highlights the limitations of current treatments in terms of efficacy over time, underscoring the need for alternative therapeutic strategies. The focus of the article is on spinal cord stimulation (SCS), which is presented as an established and cost-effective treatment for severe chronic pain. The article aims to review both the current approved indications for SCS in the United States and explore new therapeutic options available through this modality.
What’s new: The article promises to provide insights into novel therapeutic options for neuropathic pain using spinal cord stimulation, beyond the currently approved indications.
Importance: Given the limited efficacy of existing treatments for neuropathic pain, the exploration of SCS as a viable alternative could have significant implications for patient care.
Contribution to literature: This review potentially adds to the current literature by updating clinicians and researchers on the advancements and expanded applications of SCS in the management of neuropathic pain.